
New Month, New Strategy 11/3/25
Halftime Report
00:00
Are Biotech and Pharma Attractive Now?
Frank references a bullish Roth Capital note; Carrie and Joe assess Amgen, Novo Nordisk and XBI positioning amid sector weakness and entry points.
Play episode from 29:26
Transcript


